Literature DB >> 7435143

Monoamines and related enzymes in cerebral cortex and basal ganglia following transient ischemia in gerbils.

V Cvejić, D V Mićić, B M Djuricić, B J Mrsulja, B B Mrsulja.   

Abstract

The post-ischemic effects on cerebral cortex and basal ganglia monoamine levels and monoamine oxidase (MAO A and B) and catechol-O-methyl transferase (COMT) activities were evaluated in Mongolian gerbils (Meriones unguiculatus) subjected to bilateral common carotid arteries of occlusion for 15 min and reflow for 7 days. Disorders of monoamine metabolism was found in ischemic brain which persisted during the long-term post-ischemia. A rebound increase of norepinephrine and serotonin appeared in early stages (up to 1 h) of post-ischemia both in cerebral cortex and basal ganglia; a rebound increase of dopamine as found only in cerebral cortex. Thereafter, the serotonin level ws enhanced over the control level during the whole post-ischemic period whereas the levels of catecholamines were reduced particularly in basal ganglia. With respect to monoamine content and activities of monoamine degraded enzymes an oscillatory behavior was observed in the post-ischemia. Disorder of the monoamine metabolism found during post-ischemic period possibly contributes to neurological dysfunction after an ischemic insult.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7435143     DOI: 10.1007/bf00688852

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Effect of repeated cerebral ischemia on metabolites and metabolic rate in gerbil cortex.

Authors:  B B Mrsulja; W D Lust; B J Mrsulja; J V Passonneau
Journal:  Brain Res       Date:  1977-01-07       Impact factor: 3.252

2.  Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex.

Authors:  W D Lust; B B Mrsulja; B J Mrsulja; J V Passonneau; I Klatzo
Journal:  Brain Res       Date:  1975-11-14       Impact factor: 3.252

3.  Effect of ischemia on monoamine metabolism in the brain.

Authors:  R M Brown; A Carlson; B Ljunggren; B K Siesjö; S R Snider
Journal:  Acta Physiol Scand       Date:  1974-04

4.  Cerebral metabolic state following complete compression ischemia.

Authors:  B Ljunggren; R A Ratcheson; B K Siesjö
Journal:  Brain Res       Date:  1974-06-20       Impact factor: 3.252

5.  Action of cerebral ischemia on decreased levels of 3-methoxy-4-hydroxy-phenylethylgylcol sulfate, homovanillic acid and 5-hydroxy-indoleacetic acid produced by pargyline.

Authors:  B B Mrsulja; B J Mrsulja; M Spatz; I Klatzo
Journal:  Brain Res       Date:  1975-11-14       Impact factor: 3.252

6.  Cerebral energy metabolism during transient ischemia and recovery in the gerbil.

Authors:  D E Levy; T E Duffy
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

7.  Catecholamines in experimental brain ischemia.

Authors:  K Kogure; P Scheinberg; A Matsumoto; R Busto; O M Reinmuth
Journal:  Arch Neurol       Date:  1975-01

8.  Changes of some putative neurotransmitters in human cerebral infarction.

Authors:  K Jellinger; P Riederer; P Kothbauer
Journal:  J Neural Transm Suppl       Date:  1978

9.  A rapid microfluorimetric determination of monoamine oxidase.

Authors:  M Krajl
Journal:  Biochem Pharmacol       Date:  1965-11       Impact factor: 5.858

10.  Cathecholamine and 5-hydroxytryptamine levels in ischemic brain. Influence of p-chlorophenylalanine.

Authors:  K M Welch; E Chabi; J Buckingham; B Bergin; V S Achar; J S Meyer
Journal:  Stroke       Date:  1977 May-Jun       Impact factor: 7.914

View more
  13 in total

1.  Effect of transient reduction of cerebral blood flow in normotensive rats on striatal dopamine-release.

Authors:  S Läer; F Block; G Huether; C Heim; K H Sontag
Journal:  J Neural Transm Gen Sect       Date:  1993

2.  Cerebral ischemia: changes in monoamines are independent of energy metabolism.

Authors:  B B Mrsulja; B M Djuricic; Y Ueki; W D Lust; M Spatz
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

3.  Relationship of extracellular dopamine in striatum of newborn piglets to cortical oxygen pressure.

Authors:  C C Huang; N S Lajevardi; O Tammela; A Pastuszko; M Delivoria-Papadopoulos; D F Wilson
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

4.  Relationship between locomotor activity and monoamines following single and double transient forebrain ischemia in gerbils.

Authors:  M E Haque; K Tanaka; N Ogawa
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

5.  Serotonin reduction in the mouse neostriatum during hyperthermia-induced convulsions studied by immunohistochemistry.

Authors:  Y Takeuchi; K Fujiwara; K Ishimura; H Yoshioka; T Sawada
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced changes in brain monoamines and their metabolites in gerbils.

Authors:  K Haba; N Ogawa; M Asanuma; H Hirata; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1992

7.  Effect of cerebral ischemia on synaptosomal uptake and release of 3H-5-hydroxytryptamine in adult and young Mongolian gerbils.

Authors:  V Cvejic; K Kumami; M Spatz
Journal:  Metab Brain Dis       Date:  1990-03       Impact factor: 3.584

8.  Cerebral ischemia: changes in brain choline, acetylcholine, and other monoamines as related to energy metabolism.

Authors:  A Beley; N Bertrand; P Beley
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

9.  Dopamine metabolism and free-radical related mitochondrial injury during transient brain ischemia in gerbils.

Authors:  H Ishii; D B Stanimirovic; C J Chang; B B Mrsulja; M Spatz
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

10.  The effects of sho-saiko-to-go-keishi-ka-shakuyaku-to (TJ-960) on ischemia-induced changes of brain acetylcholine and monoamine levels in gerbils.

Authors:  K Haba; N Ogawa; A Mori
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.